IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Krensavage Asset Management, LLC

Q2 2018 Holdings

Filed 2018-08-13 | 14 holdings | $391.6K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
United Therapeutics Corp(UTHR)COM91307C102$62.5K552,01915.9%
Enanta Pharmaceuticals Inc(ENTA)COM29251M106$60.2K519,03515.4%
Amgen Inc(AMGN)COM031162100$45.0K243,98611.5%
Mckesson Corp(MCK)COM58155Q103$43.3K324,24311.0%
Gilead Sciences Inc(GILD)COM375558103$37.8K533,0699.6%
Merck & Co. Inc.(MRK)COM58933Y105$31.3K515,4288.0%
Shire PLCCOM82481R106$24.1K142,7586.2%
RTI Surgical IncCOM74975N105$20.5K4,465,4965.2%
Invacare CorpCOM461203101$19.7K1,061,6155.0%
Orthofix International NVCOMN6748L102$17.0K300,0494.4%
Siemens Healthineers AG(SHL)COMD6T479107$16.6K399,8154.2%
Halyard Health IncCOM40650V100$10.4K182,5022.7%
Juniper Pharmaceuticals IncCOM48203L107$2.7K308,4780.7%
Digirad CorpCOM253827109$516332,8660.1%